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Abstract
Turning genetic discoveries identified in genome-wide association (GWA) studies into biological mechanisms is an
important challenge in human genetics. Many GWA signals map outside exons, suggesting that the associated variants may
lie within regulatory regions. We applied the formaldehyde-assisted isolation of regulatory elements (FAIRE) method in a
megakaryocytic and an erythroblastoid cell line to map active regulatory elements at known loci associated with
hematological quantitative traits, coronary artery disease, and myocardial infarction. We showed that the two cell types
exhibit distinct patterns of open chromatin and that cell-specific open chromatin can guide the finding of functional
variants. We identified an open chromatin region at chromosome 7q22.3 in megakaryocytes but not erythroblasts, which
harbors the common non-coding sequence variant rs342293 known to be associated with platelet volume and function.
Resequencing of this open chromatin region in 643 individuals provided strong evidence that rs342293 is the only putative
causative variant in this region. We demonstrated that the C- and G-alleles differentially bind the transcription factor EVI1
affecting PIK3CG gene expression in platelets and macrophages. A protein–protein interaction network including up- and
down-regulated genes in Pik3cg knockout mice indicated that PIK3CG is associated with gene pathways with an established
role in platelet membrane biogenesis and thrombus formation. Thus, rs342293 is the functional common variant at this
locus; to the best of our knowledge this is the first such variant to be elucidated among the known platelet quantitative trait
loci (QTLs). Our data suggested a molecular mechanism by which a non-coding GWA index SNP modulates platelet
phenotype.
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Introduction
In recent years, genome-wide association (GWA) studies have
driven the discovery of genetic loci associated with a multitude of
complex traits and diseases. However, due to linkage disequilib-
rium (LD), the single-nucleotide polymorphisms (SNPs) assayed in
large-scale GWA studies typically yield a proxy for the actual
causative variant(s) and often fail to even pinpoint the underlying
gene [1–3]. Therefore, despite great success in biological
discovery, GWA studies have shed little light on which are the
functional variants, common and/or low-frequency, and how they
relate to biological mechanisms.
Several strategies have been proposed to identify causative
sequence variants underlying GWA signals, including fine-
mapping (i.e. targeted resequencing followed by additional
genotyping of large cohorts) and functional annotation using
biochemical assays (e.g. gene expression studies) [1,3]. Since many
initial association signals are localized at intronic and intergenic
regions, it has been postulated that they may correspond to gene
regulatory variants [4]. Therefore, functional variants may exert
their effects through regulation of gene expression, which can vary
substantially among tissues and cell types [5,6].
Integrated studies have illustrated how particular trait-associat-
ed alleles are mechanistically relevant to cellular functions and
PLoS Genetics | www.plosgenetics.org 1 June 2011 | Volume 7 | Issue 6 | e1002139pathways [7–12]. In a recent study, Gaulton et al. used the
formaldehyde-assisted isolation of regulatory elements (FAIRE)
technique to identify pancreatic islet-specific open chromatin
regions, some of which embed known diabetes risk variants [13].
FAIRE is an elegant approach to isolating nucleosome-depleted
regions (NDRs) that encompass active regulatory elements, and
thus, to accessing regulatory variants [14,15].
Heritable hematological traits are of particular interest in
studying the architecture of complex traits, since relevant cell types
for functional assays are easily accessible. In addition, genetic loci
associated with platelet counts, SH2B3–ATXN2 and PTPN11, have
been reported to be associated with coronary artery disease (CAD)
and myocardial infarction (MI) suggesting a possible role for
platelets as an intermediate phenotype [16].
Here we describe maps of open chromatin generated by FAIRE
in a megakaryocytic and an erythroblastoid cell line at known
GWA loci associated with hematological quantitative traits, CAD
and MI. We report substantial differences in chromatin architec-
ture among the two cell types and assess the phenotypic causality
of variants that fall into NDRs specific to either cell type. We
demonstrate the procedure with the locus at chromosome 7q22.3,
which is associated with mean platelet volume and function, where
we identify a site of open chromatin in megakaryocytes but not
erythroblasts and elucidate the molecular mechanism that
contributes to the platelet phenotype.
Results
Open chromatin profiles in a megakaryocytic and an
erythroblastoid cell line
We profiled chromatin at 62 non-redundant genetic loci
representing all known associations, as of November 2009, with
11 cardiovascular traits (Table 1) in a megakaryocytic (MK cells)
and an erythroblastoid cell line (EB cells). Maps of open chromatin
were created with FAIRE, applying two different formaldehyde
cross-linking times and subsequent hybridization to a custom
385,000-oligonucleotide array spanning the selected loci (Materials
and Methods). Open chromatin regions showed high concordance
across cross-linking conditions, with 95.3% and 93.1% overlap-
ping regions in MK and EB cells, respectively. To achieve higher
stringency, we retained only concordant open chromatin regions
in each cell type for further analysis (Figure S1). At the
interrogated loci, we identified 254 and 251 NDRs in MK and
EB cells, respectively (Table S1A), of which 147 (57.9% and
58.6%, respectively) were common to both cell types. FAIRE peak
density (per megabase) in our data set is consistent with that in
foreskin fibroblast cells reported by the ENCODE Project [17]
(Table S2).
Characterization of open chromatin regions in relation to
gene annotations and cell types
We then analyzed the 254 and 251 NDRs in MK and EB cells,
respectively, in context of their genomic location (intergenic,
intronic, overlap 59-untranslated region (UTR), overlap 39-UTR
or exonic; Table S3). We note that our observations are based on a
selected set of loci and therefore cannot be extrapolated to the
whole genome. NDRs were most frequently located at non-coding
segments (98.2% and 92.5% of peaks found only in MK and EB
cells, respectively, and 98.1% of peaks common to both cell types).
Promoter/59-UTR regions were enriched in NDRs common to
both cell types (28.4%) compared to open chromatin specific to
either cell type, namely 4.6% (6.2-fold) and 5.6% (5.1-fold) for MK
and EB cells, respectively.
At the interrogated loci, NDRs clustered around transcription
start sites (TSS). In MK and EB cells, 70.5% and 76.1% of all
FAIRE peaks were located within 20 kb of a TSS, respectively
(Figure S2). However, accessible chromatin regions as far as
264 kb upstream of a TSS were also detected (TBX3 gene locus).
Open chromatin observed in MK but not EB cells was located on
average 2.80 kb upstream of a TSS. NDRs found in EB but not
MK cells were located on average 1.77 kb, whereas NDRs
common to both cell types were located on average 0.98 kb
upstream of a TSS.
Author Summary
Genome-wide scans have revealed multiple genetic
regions underlying complex traits. However, the transition
from an initial association signal to identifying the
functional DNA change(s) has proved challenging. Many
of the DNA changes discovered are located outside
protein-coding regions and may exert their effects through
gene regulation. We screened genetic regions associated
with hematological traits in erythroblasts (red blood cells)
and megakaryocytes (platelet-producing cells) and
mapped sites of open chromatin, which harbor active
gene regulatory elements. We investigated a DNA
sequence change located within a site of open chromatin
at chromosome 7 in megakaryocytes, but not erythro-
blasts, known to be associated with platelet volume. We
showed that this DNA change is functional due to
alteration of the binding site of a transcription factor,
which regulates the expression of a gene that affects
platelet characteristics. Mice lacking this gene revealed
significant differences in expression of several important
platelet genes compared to wild-type mice. The approach
described here can be applied in different cell types to
functionally follow-up association signals with many other
biological traits by identification of the causative base
change and how it affects gene function, thus paving the
way to clinical benefit.
Table 1. Summary of the genetic loci included on the custom
DNA tiling array.
Complex trait
Number of
genetic loci
Genomic
footprint
Coronary artery disease (CAD) and
(early-onset) myocardial infarction (MI)
18 3,605.2 kb
Mean platelet volume (MPV) 12 1,789.7 kb
Platelet counts (PLT) 4 712.2 kb
Platelet signaling (PLS) 15 1,968.4 kb
White blood cell counts (WBC) 1 73.2 kb
Red blood cell counts (RBC) 1 50.0 kb
Mean corpuscular volume (MCV) 4 436.0 kb
Mean corpuscular hemoglobin (MCH) 1 100.0 kb
Systolic blood pressure (SBP) 6 940.0 kb
Diastolic blood pressure (DBP) 8 1,475.0 kb
Hypertension (HYP) 2 240.0 kb
Total 72 11,149.7 kb
Total unique 62 9,593.5 kb
A detailed list, including genomic coordinates of the intervals and references, is
presented in Table S9A.
doi:10.1371/journal.pgen.1002139.t001
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in our experiment, we determined the number of peaks in
lineage-specific genes for MK and EB cells present on the array
(Figure S3; Table S1B). A significant enrichment of FAIRE
peaks at MK lineage-specific genes was observed in MK cells,
when compared to the number of peaks in EB cells (Wilcoxon
rank-sum test, P=0.0225). A similar trend of enrichment was
observed in EB lineage-specific genes in EB cells (P=0.0781).
This result highlights the importance of studying chromatin
architecture and gene regulatory circuits in a cell type-dependent
manner.
Seven sequence variants associated with cardiovascular-
related quantitative traits are located in open chromatin
At seven of the 62 tested loci, we found SNPs in strong LD with
the corresponding GWA index SNP (r
2$0.8, Phase II HapMap,
CEU population) located within a NDR (Table 2). Five out of the
seven loci are associated with platelet-related quantitative trait loci
(QTLs). We compared the position of sites of open chromatin and
sites were either found only in MK but not EB cells (‘MK-specific’,
n=2), in EB but not MK cells (‘EB-specific’, n=1) or in both cell
types (n=4). The two MK-specific NDRs harboring SNPs
associated with mean platelet volume (MPV) are located at an
intergenic region of the FLJ36031–PIK3CG gene locus (Figure
S4A) and an intronic region of DNM3 (Figure S4B). Both genes,
PIK3CG and DNM3, are upregulated in megakaryocytes as
compared to erythroblasts (2.08- and 6.42-fold, respectively,
according to the HaemAtlas, a systematic analysis of expression
profiles in differentiated human blood cells) [18]. The EB-specific
NDR is located at an intergenic region of the HBS1L–MYB gene
cluster (Figure S4C). Sequence variants at this locus are known to
be associated with mean corpuscular volume (MCV) of erythro-
cytes, mean corpuscular hemoglobin (MCH) and red blood cell
counts (RBC). HBS1L and MYB are upregulated in EB cells (1.30-
and 2.40-fold, respectively, according to the HaemAtlas). At the
four NDRs common to both cell types, we found variants
associated with: platelet signaling (PLS) located at the promoter
regions of PEAR1 (Figure S4D) and RAF1 (Figure S4E); MPV
found at an intronic region of TMCC2 (Figure S4F); and systolic
blood pressure (SBP) at an intronic region of C10orf32 (CYP17A1
gene cluster; Figure S4G). Expression profiles of these genes, based
on the HaemAtlas data, confirmed transcription in both MK and
EB cells (Figure S5A).
Functional follow-up of the platelet volume and function
locus at chromosome 7q22.3
Cell-specific open chromatin regions are likely to play a
regulatory role in modulating gene expression in a cell-specific
manner. Sequence variants in such NDRs have the potential to
impact cell-specific traits, for example MPV. As a proof of
principle, we investigated the 65-kb locus associated with mean
platelet volume and function at chromosome 7q22.3 (Figure 1A),
which harbors a MK-specific NDR as described above. The
recombination interval exhibited a total of six distinct NDRs
(Figure 1B), two of which are common to both cell types located at
an evolutionary conserved element 10 kb upstream of the GWA
index SNP rs342293 and at the promoter region of FLJ36031,
three of which are specific to EB cells and one of which is specific
to MK cells. The latter NDR contained SNPs associated with
MPV: rs342293 (MAF=0.48, Phase II+III HapMap, CEU) and
its best proxy rs342294 (r
2=1.0, MAF=0.48, Phase II+III
HapMap, CEU). Data from the 1000 Genomes Project [19]
(Pilot 1, CEU) revealed 34 SNPs in LD (r
2$0.8) with rs342293,
and confirmed that only rs342293 and rs342294 fall into the MK-
specific NDR. This NDR was absent in both FAIRE-chip data sets
(8 and 12 min formaldehyde cross-linking conditions) in EB cells
(Figure 1C). Irrespective of LD to rs342293, there are no sequence
variants reported by the 1000 Genomes Project (Pilot 1, CEU)
within sites of open chromatin at the recombination interval in
MK cells.
Next, we performed an in silico analysis of transcription factor
binding sites at the 7q22.3 locus (Table S4). Of the 34 SNPs in LD
with rs342293, four (rs342240, rs342247, rs342292 and rs342293)
disrupt an in silico predicted transcription factor binding site.
However, only rs342293 is located within an experimentally
verified site of open chromatin in MK cells. Among these four
SNPs, rs342293 is the most strongly associated with mean platelet
volume [16].
The SNP rs342293 is located within overlapping predicted
binding sites for the transcription factors BARX2, EVI1, GATA1,
HHEX, HOXC8, HOXC9 and LBX2 (Figure 1D). Based on the
HaemAtlas data, of these seven transcription factors only EVI1,
GATA1 and HHEX are expressed in megakaryocytes (Figure
S5B). The C.G substitution leads to disruption of the predicted
binding sites of EVI1 and GATA1 (Figure 2A). It is worth noting
that in silico analysis predicted a RUNX1 transcription factor
binding site only 5 bp apart from the EVI1-like binding site.
Table 2. Seven sequence variants associated with cardiovascular-related and hematological intermediate traits are located in
nucleosome-depleted regions (NDRs).
Cell type Trait Locus SNP in open chromatin GWA index SNP
ID MAF Annotation ID r
2 Distance
MK MPV FLJ36031–PIK3CG rs342293 0.45 Intergenic rs342293 1.00 (index SNP)
MK MPV DNM3 rs2038479 0.16 Intronic rs10914144 0.94 10 kb
EB MCV HBS1L–MYB rs7775698 0.22 Intergenic rs9402686 0.85 9 kb
EB/MK MPV TMCC2 rs1172147 0.35 Intronic rs1668873 0.89 10 kb
EB/MK PLS PEAR1 rs4661069 0.11 Promoter rs3737224 0.83 17 kb
EB/MK PLS RAF1 rs3806661 0.30 Promoter rs3729931 0.85 79 kb
EB/MK SBP CYP17A1–C10orf32 rs3824754 0.07 Intronic rs1004467 1.00 19 kb
MK: megakaryocytic cell line; EB: erythroblastoid cell line; MPV: mean platelet volume; MCV: mean corpuscular volume of erythrocytes; PLS: platelet signaling; SBP:
systolic blood pressure; MAF: minor allele frequency.
doi:10.1371/journal.pgen.1002139.t002
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we sequenced the NDR (chr7:106,159,393–106,159,887; 494 bp)
in 643 healthy individuals. No other common or low-frequency
variants were detected, although a rare, possibly private, SNP was
detected in one individual as a heterozygous position (chr7:106,
159,601; A.C) located in a polyA-region (Table S5). Based on the
above evidence and the absence of any additional common or low-
frequency sequence variant at the MK-specific NDR, rs342293
remains as the only likely putative functional candidate underlying
the MPV association signal at the 7q22.3 locus. However, it
cannot be excluded that additional functional variants may exist
outside NDRs and exert their function through, for example
disruption of a yet to be identified transcription factor binding site
or modulation of DNA methylation.
The alleles of rs342293 differentially bind the
transcription factor EVI1
We then performed electrophoretic mobility shift assays
(EMSA) in nuclear extracts from the megakaryocytic cell line
CHRF-288-11. We observed a band shift with probes surround-
ing rs342293 for both the ancestral allele rs342293-C and the
alternative allele rs342293-G (Figure 2B). However, the bands
were unequally shifted suggesting differential protein binding
properties at this position depending on the allele of rs342293.
The specific unlabeled competitors supported specificity of the
retarded bands. Further, our results suggested superior protein
binding to the probe containing the C-allele. With supershift
experiments using an EVI1 antibody, we confirmed binding of
EVI1 to probes containing the ancestral C-allele, but not to those
harboring the alternative G-allele. Supershift experiments with a
GATA1 antibody did not support in vitro binding of GATA1
transcription factors to this site. We also confirmed RUNX1
transcription factor binding in vitro by demonstrating a supershift
for both probes with a RUNX1 antibody (Figure S6). We
validated these findings by performing chromatin immunopre-
cipitation combined with next-generation DNA sequencing
(ChIP-seq) with GATA1 and RUNX1 antibodies in primary
human megakaryocytes. We observed no significant GATA1 but
weak RUNX1 binding at this locus further corroborating the
EMSA results (Figure S7).
The SNP rs342293 is associated with PIK3CG transcript
levels in platelets and macrophages
Soranzo et al. investigated the association of rs342293 with
transcript levels of all known genes within 1 Mb of the GWA index
SNP (Figure S5C) in platelets and reported a weak expression
QTL (eQTL) association with PIK3CG transcript levels (permu-
tation P=0.047) [20]. We replicated this finding in an indepen-
dent sample cohort of 24 healthy individuals showing the same
genotypic effect (P=0.0542; Figure 3A). In both sample cohorts,
none of the other genes within the 1-Mb interval, PRKAR2B,
HBP1, PBEF1 and COG5, had a statistically significant eQTL with
rs342293 (P.0.1; data not shown). Next, we assessed the PIK3CG-
eQTL in three different types of white blood cells, macrophages,
monocytes and B cells (lymphoblastoid cell line, LCLs), as well as
in different tissues, fat and skin (Table S6). We observed a
genotypic effect on PIK3CG transcript abundance in macrophages
(P=0.0018; Figure 3B), but not in monocytes and LCLs. Further,
we did not observe an association in fat and skin tissues. Our data
strengthened the evidence of rs342293 modulating PIK3CG
transcript levels in platelets and showed that this eQTL is also
present in macrophages.
Figure 1. Functional follow-up of the 7q22.3 locus associated with platelet volume and function. (A) Regional plot of the 7q22.3 locus
showing data from the discovery GWA meta-analysis as reported by Soranzo et al. The SNP rs342293 is indicated in purple (P=6.75 610
213).
Values for r
2 are based on the 1000 Genomes Project (Pilot 1, CEU). The data was plotted with LocusZoom v1.1 (http://csg.sph.umich.edu/
locuszoom/). (B) Sites of open chromatin marked by FAIRE across the locus in the CHRF-288-11 (MK) and K562 (EB) cell lines (data uploaded as
UCSC Genome Browser custom tracks). (C) Site of open chromatin found in MK but not EB cells harboring the common variants rs342293 and
rs342294. (D) In silico annotation of transcription factor binding sites at the open chromatin region described in (C). The predicted binding
events are shown as transcription factor matrices (MatInspector v8.01). Note that some predicted binding sites are overlapping and not
visible.
doi:10.1371/journal.pgen.1002139.g001
Figure 2. The effect of rs342293C.G on transcription factor
binding. (A) Nucleotide sequence of the synthetic probe harboring
rs342293 and in silico prediction of transcription factor binding sites.
The major (C-) allele of rs342293 is shown in bold. The minor (G-) allele
of rs342293 is predicted to disrupt the binding motifs of the
transcription factors GATA1 (2 strand) and EVI1 (2). RUNX1 (+) and
HHEX (+) transcription factor binding sites are predicted to be located
9 bp and 1 bp apart from rs342293, respectively. (B) Electrophoretic
mobility shift assays (EMSA) in nuclear extracts from the megakaryocytic
cell line CHRF-288-11 showed differential binding of the two alleles of
rs342293. Competition reactions were performed with a 200-fold molar
excess of unlabeled probes. Only the probe harboring the reference
allele was able to shift the protein-DNA complex when incubating with
EVI1 antibodies. Supershift experiments using GATA1 and RUNX1
antibodies are shown in Figure S6.
doi:10.1371/journal.pgen.1002139.g002
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2/2
mice
To further our understanding of the role of PIK3CG in platelets,
we performed whole-genome gene expression profiling in whole
blood of Pik3cg knockout mice. We identified 220 differentially
expressed genes between knockout (n=3) and wild type mice (n=3)
with a fold-change of at least 61.5 (Table S7). Functional ontology
classification of these genes (Table S8) revealed enrichment for
‘regulation of biological characteristic’, e.g. cell size and volume
(GO term: 0065008;P=2.97610
214), and ‘blood coagulation’ (GO
term: 0007596; P=7.87610
212). Notably, this gene list includes
Gp1bb (fold-change of 22.203 in Pik3cg
2/2 compared to wild type
mice), Gp5 (23.211), Gp9(20.996), Gp6(20.711) and Vwf(21.381).
All five genes are transcribed in the megakaryocytic lineage in
humans, based on the HaemAtlas data. The platelet glycoproteins
GP1BB, GP5 and GP9, together with GP1BA constitutethe platelet
membrane receptor for the plasma protein Von Willebrand Factor
(VWF), which is encoded by VWF [21].
Canonical pathway enrichment analysis and protein–
protein interaction network
To explore the signaling pathways of PIK3CG in humans, we
analyzed 191 human orthologs of the 220 differentially expressed
genes between Pik3cg
2/2 and wild type mice. Canonical pathway
enrichment analysis based on the curated gene sets of the
Molecular Signatures Database (MSigDB) v3.6 [22] revealed that
the top six enriched gene sets were related to platelets: ‘platelet
degranulation’ (P=3.44610
28), ‘platelet activation’ (P=5.056
10
28), ‘formation of platelet plug’ (P=2.85610
27), ‘hemostasis’
(P=7.48610
26), ‘formation of fibrin clot and clotting cascade’
(P=1.39610
25) and ‘platelet adhesion to exposed collagen’ (P=
1.86610
25).
We constructed a protein-protein interaction network centered
on the proteins encoded by the 191 transcripts described above.
First-order interactors of these ‘core’ proteins were obtained from
Reactome, an open-source manually curated database of human
biological pathways [23,24]. We filtered interactors on their
expression levels in MK cells (Materials and Methods). The
resulting network incorporated 45 core proteins centered on
PIK3CG consisting of 642 nodes and 1067 edges (Figure 4).
Discussion
The intersection of maps of open chromatin with variants
identified through GWA studies can facilitate the search for
underlying functional variant(s). We applied the FAIRE assay to
generate a catalog of NDRs in a megakaryocytic and an
erythroblastoid cell line at 62 selected genetic loci associated with
hematological and cardiovascular traits. We provided evidence
that open chromatin profiles exhibit distinct patterns among
different cell types and that cell-specific NDRs can be useful in
prioritizing regions for further functional analysis. As proof, we
elucidated the molecular basis of the association with mean
platelet volume and function at chromosome 7q22.3. We
identified a NDR in MK but not EB cells containing the index
SNP rs342293 for this association and demonstrated that the
alleles of rs342293 differentially bind the transcription factor
EVI1. Thus, to the best of our knowledge this is the first functional
variant to be elucidated among the known platelet QTLs.
Expression QTL data in platelets and macrophages provided
statistical support that rs342293 affects PIK3CG gene expression
levels. PIK3CG is transcribed in megakaryocytes but only weakly
expressed in erythroblasts [18], which is in agreement with the
MK-specific properties of the identified NDR. However, addi-
tional work is required to scrutinize all possible targets of this
regulatory module. The closest gene FLJ36031, which spans only
2 kb, has no reported protein product and function and requires
further characterization. PIK3CG is located 134 kb downstream of
rs342293 and encodes the phosphoinositide-3-kinase c-catalytic
subunit. The lipid kinase PIK3CG (PI3Kc) is a member of the
class I PI3Ks and catalyzes the conversion of phosphatidylinositol-
4,5-bisphosphate (PtdIns(4,5)P2; PIP2) to phosphatidylinositol-
3,4,5-trisphosphate (PtdIns(3,4,5)P3; PIP3) downstream of cell
surface receptor activation [25–27]. In megakaryocytes and
platelets, PIP3 is crucial in the collagen-induced regulation of
phospholipase C and initiation of megakaryopoiesis and proplate-
let formation [28]. Functional studies with Pik3cg knockout mice
have indicated a role in wound healing [29], ADP-induced platelet
aggregation and thrombosis [30,31]. It is noteworthy that
PIK3CG has also a prominent role in macrophage activation [27].
Whole-genome gene expression profiling in Pik3cg
2/2 mice
showed differential expression of genes involved in important
platelet-related pathways compared to wild type mice, most
notably Vwf and its platelet membrane receptor components.
Our recent meta-analysis of GWA studies in 68,000 Northern
Europeans showed that common sequence variation at the VWF
and GP1BA loci exert an effect on platelet volume and counts,
respectively (NS, unpublished data). This recent finding together
with the established knowledge that Mendelian mutations in the
genes encoding the platelet VWF (Von Willebrand disease, type 2;
OMIM: 613554) and its receptor (Bernard-Soulier syndrome;
OMIM: 231200) are causative of giant platelets, give biological
credence to the observed effects of Pik3cg knockout on the
transcription of these platelet genes. The protein-protein interac-
tion network centered on PIK3CG highlighted additional proteins
implicated in severe platelet disorders, including TUBB1 (macro-
thrombocytopenia, autosomal dominant, TUBB1-related; OMIM:
613112), F5 (factor V deficiency; OMIM: 612309) and P2RY12
Figure 3. Association of rs342293 genotypes with PIK3CG
transcript levels in platelets and macrophages. In platelets (A)
and macrophages (B), we observed a genotypic effect on PIK3CG
transcript levels (P=0.0542 and P=0.0018, respectively). The associa-
tions are presented as box-and-whisker plots. In macrophages, the
proxy-SNP rs342275A.G( r
2=0.94, Phase II HapMap, CEU) was used for
the eQTL analysis.
doi:10.1371/journal.pgen.1002139.g003
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Therefore, it is plausible to assume that differences in the PIK3CG
transcript levels in humans, based on the different alleles of
rs342293, may lead to changes in the abundance of platelet
membrane proteins that are key regulators of platelet formation.
We previously showed an association of rs342293-G with
decreased platelet reactivity in humans, assessed as the proportion
of binding to annexin V and fibrinogen, as well as P-selectin
expression, after activation of platelets with collagen-related
peptide (CRP-XL) [20]. We also observed that rs342293 is likely
to modify events downstream of signaling via the collagen
signaling receptor glycoprotein VI, which is encoded by GP6
[32]. A recent GWA study showed the same locus at chromosome
7q22.3 to be associated also with epinephrine-induced platelet
aggregation [33]. The index SNP in that study, rs342286, and
rs342293 are in high LD (r
2=0.87, Phase II HapMap, CEU)
making rs342293 the putative causative variant underlying both
functional associations. The observation that platelet functional
events triggered via an immunoreceptor tyrosine-based activation
motif on the Fc receptor c-chain (ITAM-FcR-c) or G-protein-
coupled receptor, for collagen and epinephrine, respectively, are
both modified by differences in the PIK3CG transcript level is
compatible with the notion that both signaling cascades require
PIP3 and that silencing of Pik3cg in mice reduces the expression of
the Gp6 gene.
Based on the above data, we propose a model (Figure 5) in
which the DNA sequence containing the C- but not the G-allele of
rs342293 binds the transcription factor EVI1, which acts as
transcriptional repressor of PIK3CG in megakaryocytes and
ultimately affects platelet phenotype.
EVI1 (ecotropic viral integration site-1) encodes a protein
with two zinc-finger domains (ZF1 and ZF2), which feature
Figure 4. Protein–protein interaction network centered on PIK3CG. A protein-protein interaction network was constructed centering on the
human orthologous proteins encoded by the 220 differentially expressed transcripts between Pik3cg knockout and wild type mice with a fold-change
of at least 61.5. The color of these ‘core’ proteins represents the fold-change of gene transcript levels between Pik3cg
2/2 and wild type mice on a
continuous scale from over- (red) to underexpression (blue) of transcripts in knockout mice. Core proteins, which do not exhibit first-order interactors
in the Reactome database and are disconnected from the largest connected component, are not shown. First-order interactors of PIK3CG that form
network nodes and edges are shown in grey and were obtained from Reactome. Interactors that are not expressed in MK cells based on the
HaemAtlas data are omitted. The resulting network consists of 45 core proteins with 642 nodes and 1067 edges.
doi:10.1371/journal.pgen.1002139.g004
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hematopoietic differentiation into the megakaryocytic lineage.
EVI1 was frequently reported to be a repressor of transcription
that has the potential to recruit diverse regulatory proteins. For
example, EVI1 antagonizes the growth-inhibitory effect of
transforming growth factor-b (TGF-b), a potent regulator of
megakaryopoiesis [35], by interacting with SMAD3 via ZF1,
and inhibiting SMAD3 from binding to DNA [36,37]. EVI1
contains domains that interact with RUNX1 (Runt-related
transcription factor 1), which is the a-subunit of the transcription
factor CBF (core binding factor). The interaction of EVI1 with the
DNA-binding domain Runt of RUNX1 leads to the destabilization
of the DNA-RUNX1 complex and subsequent loss of RUNX1
function [38].
By converting the read-out system from microarrays to high-
throughput next-generation sequencing, genome-wide open chro-
matin profiles can be interrogated. This would scale up analysis to
the whole genome generating a catalog of open chromatin profiles
to annotate association loci identified in past and future GWA
studies. Furthermore, resources such as the completed 1000
Genomes Project will make the requirement for resequencing any
identified NDR redundant. However, access to cell types relevant
to the studied trait is not always feasible and can be a limitation for
functional studies. For instance, we did not observe any
intersection of FAIRE peaks with variants associated with CAD/
MI or hypertension indicating that cell types other than the
megakaryocytic and erythroblastoid cell lines analyzed here may
be more suitable.
In addition to rs342293, we identified six putative functional
variants associated with hematological and cardiovascular traits
that fall into open chromatin (Table 2). Follow-up functional
studies of these variants will further test the applicability of the
approach we have proposed here. For example, the MK-specific
NDR containing rs2038479 was found to mark an alternative
promoter of a dynamin 3 (DNM3) transcript with expression
restricted to the megakaryocytic lineage (WHO, unpublished
data). Correlation of signatures of open chromatin with experi-
mentally determined transcription factor binding sites studied in
different cell types can systematically and rapidly translate GWA
signals into functional components and biological mechanisms,
thus paving the way to clinical benefit.
Materials and Methods
Ethics statement
All human subjects were recruited with appropriate informed
consent in Cambridgeshire and enrolled in the Cambridge
BioResource (http://www.cambridgebioresource.org.uk/). The
study has ethical approval from the NHS Cambridgeshire
Research Ethics Committee. The care and use of all mice in this
study was carried out in accordance with the UK Home Office
regulations under the Animals (Scientific Procedures) Act 1986.
DNA tiling microarray design
We designed a 385,000-oligonucleotide tiling array (Roche
NimbleGen) using 72 known genetic loci associated with the traits
listed in Table 1 (National Human Genome Research Institute
catalog of published GWA studies, http://www.genome.gov/
gwastudies/). We considered only genetic loci that reached
genome-wide significance with the threshold of P,5610
28 (or
as otherwise indicated in Table S9A) in a GWA study conducted
with individuals of Northern and Western European ancestry
(CEU population). In addition, we selected genetic loci based on
biological evidence, where there was suggestive evidence of
association. For each locus, we included the entire genetic region
of the index SNP as defined by recombination hotspots based on
Phase II HapMap [39]. If a recombination interval exceeded
500 kb, we included the closest target gene 610 kb. In order to
assess patterns of cell type specificity, we included eight lineage-
specific reference genes for each of megakaryocytes, erythroblasts
and monocytes on the array (Table S9B). We selected these
transcripts on the basis of their expression profiles (Figure S5D)
[18]. The oligonucleotide (50–75-mer probes) tiling array provided
a mean probe span of 23 bp and harbored only probes unique to
the human genome (build: hg18, coverage: 79%). In summary, a
total of 62 unique complex trait loci and 24 reference gene loci
representing 9.59 Mb and 1.77 Mb of genomic DNA, respective-
ly, were selected for the array design.
Formaldehyde-assisted isolation of regulatory elements
(FAIRE)
We performed FAIRE in the human cell lines CHRF-288-11
and K562 on tiling arrays. Both cell lines exhibit markers
Figure 5. Model of the mechanism by which rs342293 may affect platelet volume. Based on our data, we propose that rs342293C.G
affects EVI1 transcription factor binding at the megakaryocyte-specific site of open chromatin at chromosome 7q22.3. The underlying DNA sequence
around rs342293 (indicated in red) is shown and transcription factor binding motifs for RUNX1 (green) and EVI1 (purple) are highlighted. The
transcriptional complex of EVI1 is a well-described repressor of gene transcription. In platelets, individuals with homozygous rs342293-C have lower
PIK3CG gene expression levels compared to subjects with homozygous rs342293-G. In Pik3cg knockout mouse models, transcripts that encode key
proteins for platelet membrane biogenesis were found to be downregulated, which may ultimately affect platelet phenotype.
doi:10.1371/journal.pgen.1002139.g005
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blasts [42,43], respectively. CHRF-288-11 cells were maintained
in RPMI-1640 medium, supplemented with 20% horse serum
(heat-inactivated) and 1% L-glutamine-penicillin-streptomycin
solution. K562 cells were maintained in RPMI-1640 medium,
supplemented with 10% fetal bovine serum (non-heat-inactivated),
2 mM GlutaMAX-I and 1% L-glutamine-penicillin-streptomycin
solution. Cells were grown at 37uC, 5% CO2 and 100%
humidified atmosphere. FAIRE experiments were carried out as
previously described [44]. Briefly, for each cell type, 20610
6 cells
were cross-linked with 1% formaldehyde for 8 or 12 min.
Chromatin was extracted and subjected to 12 sonication cycles
(30 sec of high pulse, 30 sec of rest) using the Bioruptor UCD-200
(Diagenode). DNA fragments depleted of proteins (‘open chroma-
tin’) were phenol-chloroform extracted and ethanol precipitated.
The samples were treated with RNase A and cleaned-up using the
MinElute PCR Purification Kit (QIAGEN). A DNA amplification
step was not applied.
Detection of FAIRE DNA
DNA extracted from cross-linked cells (FAIRE, input sample)
and uncross-linked cells (reference sample) were labeled with Cy5
and Cy3 dye, respectively, and subsequently co-hybridized to the
tiling array. Dual-color sample labeling, array hybridization,
washing and scanning were performed using the dual-channel
microarray platform by Roche NimbleGen according to the
manufacturer’s protocol (NimbleGen Arrays User’s Guide, ChIP-
chip Analysis v4.1).
FAIRE data analysis
Experimental data were analyzed using the software Nimble-
Scan v2.5 (Roche NimbleGen). The two-channel raw signal
intensities were scaled between channels by subtracting the Tukey
bi-weight mean for the log2-ratio values for all features from each
log2-ratio value. In the scaled log2-ratio data, peaks were identified
using a sliding window approach [45]. For each chromosome, the
log2-ratio cut-off value was calculated as the percentage of a
hypothetical maximum (Pmax=arithmetic mean+66 standard
deviation). The peak finding process was repeated using a series
of log2-ratio cut-off values from Pstart to Pend. The following
settings for the peak-finding analysis were applied: sliding window:
300 bp; min. probes.cut-off in peak=4; all probes in peak.
cut-off=2; Pstart=90%, Pend=15%, Pstep=0.5, number of steps:
100. Log2-ratio and peak data sets were displayed as UCSC
Genome Browser (http://genome.ucsc.edu/) custom tracks. For
the geno-
mic characterization of FAIRE peaks, we extracted all annotation
from the Ensembl database v54 (build: hg18). Proxy-SNPs to
reported GWA index SNPs were gathered using the Genome-wide
Linkage Disequilibrium Repository and Search Engine (GLID-
ERS) [46], with the following settings: Phase II HapMap v23
(CEU); MAF limit$0.05; r
2 limit$0.8; no distance limits. The
FAIRE microarray data sets are available online in the Gene
Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.
gov/geo/) under accession number GSE25716.
Capillary DNA sequencing
DNA samples from a total of 643 individuals of Northern
European ancestry were subjected to capillary DNA sequencing
of the targeted locus at chromosome 7q22.3. Details of the
sequencing protocol are described online (http://www.sanger.ac.
uk/resources/downloads/human/exoseq.html). DNA was ampli-
fied by PCR and applied to bi-directional sequencing using Big
Dye chemistry on 3730 DNA sequencers (Applied Biosystems).
We used the following primer pairs (for two sequence-tagged
sites): 59-TGG AAA ATT ACA AAA GTC CCA AA, 59-GAG
AAA GGA TCA TGA GGG AGA A; and 59-ACA AAA GTC
CCA AAA TTT CAC A, 59-GAG AAA GGA TCA TGA GGG
AGA. The resulting products map to the following genomic
location: chr7:106,159,328–106,159,998 (671 bp) and chr7:106,
159,337–106,159,998 (662 bp). Pre-processed sequence traces
were analyzed using the semi-automated analysis software
ExoTrace, developed at the Wellcome Trust Sanger Institute
(http://www.sanger.ac.uk/resources/downloads/human/exoseq.
html). Potential SNP positions were indicated by the software and
then reviewed manually.
Transcription factor binding site analysis
In silico transcription factor binding sites were predicted using
the software MatInspector v8.01 [47], with the following param-
eters: matrix group: vertebrates; core=1.00; matrix=opti-
mized+0.02; tissue: hematopoietic system.
Electrophoretic mobility shift assay (EMSA)
Nuclear extract was prepared from CHRF-288-11 cells with the
NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo
Fisher Scientific). Oligonucleotides were designed based on the
genomic sequence surrounding rs342293; the SNP position is
shown in bold: 59-biotin-AGC CCT GTG GTT TTA ATT
ATC/G TTG AGG TTC AGG CTC A. Competitor probes
were prepared without biotin tags. The labeled strands were
annealed with the unlabeled complementary strands using a
standard protocol. All oligonucleotides were provided by Sigma-
Aldrich. We performed gel mobility shift assays with the LightShift
Chemiluminescent EMSA Kit (Thermo Fisher Scientific) accord-
ing to the manufacturer’s protocol. Each 20-ml binding reaction
contained 16 binding buffer, 75 ng/ml poly(dI/dC), 2.5%
glycerol, 0.05% NP-40, 87.5 mM KCl and 6.25 mM MgCl2.
For competition assays, we used 200-fold molar excess of the
unlabeled probe. Reactions were incubated for 2 hr at room
temperature. Supershift experiments were performed with EVI1
(sc-8707 X, Santa Cruz Biotechnology), GATA1 (ab28839,
Abcam) and RUNX1 (sc-28679 X, Santa Cruz Biotechnology)
antibodies.
Expression QTL analysis
Gene expression profiling and genotypic data sets were obtained
from different sources depending on the studied cell type. RNA
from all studied cell types was isolated using a TRIZOL standard
protocol. Total RNA was quantified using the NanoDrop (Labtech
International) and quality-checked using the 2100 Bioanalyzer
(Agilent Technologies). Standard protocols were applied to
generate biotinylated cRNA and hybridize to Illumina BeadChips
(platelets: HumanWG-6 v2; macrophages/monocytes: Human-
Ref-8 v3; LCLs/fat/skin: HumanHT-12 v3). Then, arrays were
washed and scanned. All experimental procedures were carried
out according to the manufacturer’s protocol. Even though
different versions of Illumina platforms were used, the probe for
PIK3CG is the same across all chips (probe-ID: ILMN_1770433).
Genotyping was performed on DNA extracted from whole blood
using TaqMan (Applied Biosystems) SNP genotyping assays
(platelets study) and Illumina SNP arrays (macrophages/mono-
cytes study: Human 1.2M-Custom and Human 670-Quad-
Custom; LCLs/fat/skin study: Human 1M-Duo) following the
manufacturer’s instructions. Expression QTL analysis with
rs342293 or its proxy-SNP was performed with the software
Genevar (Gene Expression Variation) using a window of 61M b
centered on the SNP [48]. The strength of the relationship
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Spearman’s rank correlation and reported as nominal P-values.
Whole-genome gene expression profiling of Pik3cg
2/2
mice
Pik3cg knockout mice were obtained from sources previously
described [49], backcrossed onto the C57BL/6J Jax genetic
background for eight generations (B6J;129-Pik3cg
tm1Pngr) and then
maintained as a closed colony by intercrossing from within the
colony (C57BL/6J Jax contribution: 99.6%). We performed PCR
genotyping using a standard protocol with the following primer
pairs: 59-TCA GGC TCG GAG ATT AGG TA, 59-GCC CAA
TCG GTG GTA GAA CT (wild type); 59-GGA CAC GGC TTT
GAT TAC AAT C, 59-GGG GTG GGA TTA GAT AAA TG
(mutant) [49]. Whole blood from three Pik3cg
2/2 and three
C57BL/6J Jax wild type mice (all females, age: 13–16 weeks,
Mouse Breeders Diet (Lab Diets 5021-3)) was collected from
terminally anesthetized mice via the retro-orbital sinus. We
extracted total RNA using the Mouse RiboPure-Blood RNA
Isolation Kit (Ambion). Total RNA was quantified using the
NanoDrop and quality-checked using the 2100 Bioanalyzer.
Standard protocols were used to generate biotinylated cRNA
and hybridize to MouseWG-6 v2 Expression BeadChips. Arrays
were washed, detected and scanned. All experimental procedures
were carried out according to the manufacturer’s protocol. On the
raw expression data, we performed background subtraction,
variance-stabilizing transformation and quantile normalization
across all samples with the R package lumi (http://bioconductor.
org/packages/release/bioc/html/lumi.html). Technical replicates
were averaged and the differentially expressed transcripts between
wild type and knockout mice were identified by calculating the
log2-fold changes of the averaged expression values. P-values were
calculated by 1-way analysis of variance (ANOVA). We performed
gene ontology term enrichment analysis using AmiGO v1.7 [50],
with the following parameters: gene expression fold-change cut-
off: 61.5; background: MGI; P-value cut-off: 1610
25; minimum
number of gene products: 10. The whole-genome gene expression
data sets of Pik3cg
2/2 and wild type mice are available online in
the GEO database under accession number GSE26111.
Protein–protein interaction network
Of the 220 differentially expressed genes between Pik3cg
2/2 and
wild type mice, we retrieved 191 orthologous human genes using
BioMart (http://www.ensembl.org/biomart/martview/) and their
respective proteins using UniProt (http://www.uniprot.org/).
These ‘core’ proteins were used as primary seeds to develop the
protein-protein interaction network. We determined first-order
interactors of core proteins using Reactome v36. Only clustered
non-redundant first-level interactions between human proteins
that were connected to the largest connected component were
considered. Based on the HaemAtlas data, we neglected
interactors that are not expressed in MK cells (P.0.01). The
described network is available for download in Cytoscape v2.8.0
format (Dataset S1).
Supporting Information
Dataset S1 PIK3CG protein–protein interaction network.
(BZ2)
Figure S1 Analytical approach for peak calling in FAIRE-chip
data sets. FAIRE was performed with different formaldehyde
cross-linking times (8 and 12 min). In order to reduce experimen-
tal error and achieve higher stringency, replicated and overlapping
peaks were merged for each cell type and subjected to further
analysis.
(TIF)
Figure S2 Location of the open chromatin sites in respect to the
closest transcription start site (TSS) at the selected association
loci.
(TIF)
Figure S3 Average number of FAIRE peaks in lineage-specific
genes in MK and EB cells. The number of open chromatin sites in
lineage-specific genes (62 kb) was averaged and normalized for
the length of the gene.
(TIF)
Figure S4 Maps of open chromatin at the selected genetic loci in
MK and EB cells displayed as UCSC Genome Browser custom
tracks. (A) FLJ36031–PIK3CG; (B) DNM3; (C) HBS1L–MYB; (D)
PEAR1; (E) RAF1; (F) TMCC2; (G) CYP17A1–C10orf32. Shown are
the scaled log2-ratio and the called peaks from FAIRE experiments
in an erythroblastoid (blue) and a megakaryocytic cell line (red).
Only the data sets using a formaldehyde fixation time of 12 min
are shown for both cell types. The putative regulatory SNP located
within a site of open chromatin is shown below each track.
(PDF)
Figure S5 Gene expression profiles. The heat maps show
normalized gene expression profiles in differentiated human blood
cells according to the HaemAtlas (Materials and Methods). (A)
Gene loci that harbor cell type-specific open chromatin and
putative regulatory sequence variants; (B) Transcription factors
predicted to bind DNA sequence motifs around rs342293; (C)
Genes within a 1-Mb interval of rs342293; (D) Lineage-specific
reference genes.
(TIF)
Figure S6 Gel shift assays in CHRF-288-11 nuclear extracts
using GATA1 and RUNX1 antibodies. No supershift was
observed when incubating CHRF-288-11 nuclear extract with
GATA1 antibodies for probes containing either rs342293-C or -G.
However, we showed evidence for RUNX1 transcription factor
binding in vitro. Reactions were incubated for 1 hr at room
temperature.
(TIF)
Figure S7 No significant GATA1 but weak RUNX1 binding at
the MK-specific open chromatin region at chromosome 7q22.3.
Cord blood-derived CD34-positive hematopoietic progenitor cells
were seeded at 1610
5 in CellGro SCGM (CellGenix) in the
presence of 100 ng/ml recombinant human thrombopoietin
(CellGenix) and 10 ng/ml interleukin-1b (Miltenyi Biotec) for 10
days, after which 71% of cells expressed CD41. ChIP was
performed as previously described [51] with GATA1 (ab11963,
Abcam) and RUNX1 (ab23980, Abcam) antibodies. Samples were
amplified and sequenced on the Illumina Genome Analyzer II
following manufacturer’s instructions. Data were transformed into
density plots and displayed as UCSC Genome Browser custom
tracks. Visual inspection of the 7q22.3 region showed no in vivo
binding of GATA1, but weak RUNX1 binding. In total, the ChIP-
seq data sets comprised 4,722 and 7,345 peaks for GATA1 and
RUNX1, respectively [52].
(TIF)
Table S1 FAIRE peak data sets. The genomic positions of
FAIRE peaks are reported at (A) the association loci and (B) the
lineage-specific reference genes.
(PDF)
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ENCODE and the here presented data sets.
(PDF)
Table S3 Characterization of open chromatin regions in relation
to gene annotations.
(PDF)
Table S4 Investigation of the functional role of platelet volume-
associated variants at chromosome 7q22.3.
(PDF)
Table S5 Resequencing of the MK-specific open chromatin
region at chromosome 7q22.3.
(PDF)
Table S6 Expression QTL associations at the PIK3CG gene
locus in platelets, macrophages, monocytes, B cells (LCLs), fat, and
skin.
(PDF)
Table S7 Differentially expressed genes between Pik3cg
2/2 and
wild-type mice.
(PDF)
Table S8 Functional ontology classification of differentially
expressed genes between Pik3cg
2/2 and wild-type mice.
(PDF)
Table S9 Genetic loci selected for the high-density DNA tiling
array.
(PDF)
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